Oxidized Phospholipids Inhibit the Formation of Cholesterol-Dependent Plasma Membrane Nanoplatforms

Biophys J. 2016 Jan 5;110(1):205-13. doi: 10.1016/j.bpj.2015.11.018.

Abstract

We previously developed a single-molecule microscopy method termed TOCCSL (thinning out clusters while conserving stoichiometry of labeling), which allows for direct imaging of stable nanoscopic platforms with raft-like properties diffusing in the plasma membrane. As a consensus raft marker, we chose monomeric GFP linked via a glycosylphosphatidylinositol (GPI) anchor to the cell membrane (mGFP-GPI). With this probe, we previously observed cholesterol-dependent homo-association to nanoplatforms diffusing in the plasma membrane of live CHO cells. Here, we report the release of this homo-association upon addition of 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine (POVPC) or 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine, two oxidized phospholipids (oxPLs) that are typically present in oxidatively modified low-density lipoprotein. We found a dose-response relationship for mGFP-GPI nanoplatform disintegration upon addition of POVPC, correlating with the signal of the apoptosis marker Annexin V-Cy3. Similar concentrations of lysolipid showed no effect, indicating that the observed phenomena were not linked to properties of the lipid bilayer itself. Inhibition of acid sphingomyelinase by NB-19 before addition of POVPC completely abolished nanoplatform disintegration by oxPLs. In conclusion, we were able to determine how oxidized lipid species disrupt mGFP-GPI nanoplatforms in the plasma membrane. Our results favor an indirect mechanism involving acid sphingomyelinase activity rather than a direct interaction of oxPLs with nanoplatform constituents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • CHO Cells
  • Cell Membrane / drug effects*
  • Cell Membrane / metabolism*
  • Cholesterol / metabolism*
  • Cricetinae
  • Cricetulus
  • Glycosylphosphatidylinositols / metabolism
  • Humans
  • Microscopy
  • Nanotechnology*
  • Oxidation-Reduction
  • Phospholipid Ethers / pharmacology*

Substances

  • 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine
  • 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine
  • Glycosylphosphatidylinositols
  • Phospholipid Ethers
  • Cholesterol